Browse > Article
http://dx.doi.org/10.6116/kjh.2018.33.5.1.

Hepatoprotecive Effects of Puerariae Flos Extract on Experimental Non-alcoholic Fatty Liver Disease Models  

Hwang, Hyeong-Chil (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Kong, Ryong (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Kang, Ok-Hwa (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Kwo, Dong-Yeul (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Publication Information
The Korea Journal of Herbology / v.33, no.5, 2018 , pp. 1-8 More about this Journal
Abstract
Objectives : The aim of this study is to investigate the preventive effect of Puerariae Flos ethanol extract (PE) on methionin and choline deficient (MCD)-diet-induced Nonalcoholic fatty liver disease (NAFLD) in C57BL/6J mice. Methods : In the in vivo experiments, C57BL/6J mice were divided into 4 groups; Normal group, Control group, MCD+PE 100 group, and MCD+PE 300 group. After 4 weeks, body weight, liver weight, biochemical parameters for liver function test, histological changes, reverse transcription polymerase chain reaction (RT-PCR), and Western blot were assessed. Results : Mice lost body weight with the MCD-diet and the MCD+PE 100 group and MCD+PE 300 groups lost less than the control group, though showed no statistical significance. Liver weights were decreased by the MCD diet, but MCD+PE 300 groups were increased significantly. In the liver function test, all the values were decreased with the MCD-diet, MCD+PE 100 group and MCD+PE 300 groups were increased significance. In histological findings of the livers, MCD-diet induced severe fatty accumulation in the livers, but this fatty change was reduced in the MCD+PE 100 group and MCD+PE 300 groups was inhibited respectively. In lipid accumulation factors (such as SREBP-1c, $C/EBP{\alpha}$, PPAR-${\gamma}$), MCD+PE 100 group and MCD+PE 300 groups showed inhibitory effect on liver lipogenesis by reducing associated gene expressions caused by MCD diet. Conclusions : We were able to know that Puerariae Flos ethanol extract (PE) shown hepatoprotective effects via a decrease on the hepatic lipogenesis factors in the experimental NAFLD Models.
Keywords
Puerariae Flos; NAFLD; MCD-diet;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74-80.   DOI
2 Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Path. 1989;20:594-598.   DOI
3 Bacon BR, Faragvash MJ, Janny CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an espanded clinical entity. Gastroenterology. 1994;107:1103-1109.   DOI
4 Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in sterptozotocin-induced diabetic rats. J Nature Products. 2003;66:788-792.   DOI
5 Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharmacal Res. 2007;30:1309-1317.   DOI
6 Gervois P, Torra IP, Fruchart JC, Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med. 2000;38:3-11.
7 Foretz M, Guichard C, Ferre P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci. 1999;96:12737-12742.   DOI
8 Morrison CD, Huypens P, Stewart LK, Gettys TW. Implications of cross talk between leptin and insulin signaling during the development of dietinduced obesity. Biochim Biophys Acta. 2009;1792: 409-416.   DOI
9 Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV and O'Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact. 2007;165(2):106-116.   DOI
10 Ko JS. Dermatology. Soomoonsa Press. 2000:73.
11 Pavel S, Muskiet FA. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma, a preliminary report. Cancer Detect Prev. 1983;6:311-316.
12 Prota, G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980;75:122-127.   DOI
13 Masashi N, Yasuteru K,Tooru S. Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis. 2012;2013:237870. doi: 10.1155/2013/237870.   DOI
14 Parvez S, M Kang, HS Chung, C Cho, MC Hong, MK Shin, H Bae. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res. 2006;20:921-934.   DOI
15 Mayer A. M. Polyphenol oxidases in plants recent progress. Phytochemistry. 1987;26:11-20.
16 Cabanes JS, Chazarra S, Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow binding inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol. 1994;46:982-985.   DOI
17 Kim CM, Sin MK, Lee KS, Ahn DK. Encyclopedia of oriental herbal medicine. Seoul:Jeongdam. 2004;2307.
18 Andrew J Lickteig, Craig D Fisher, Lisa M Augustine, Nathan J. Cherrington. Genes of the Antioxidant Response Undergo Upregulation in a Rodent Model of Nonalcoholic Steatohepatitis. J Biochem Molecular Toxicology. 2007;219:216-220.
19 Mu Y-ping, Ogawa T, Kawada N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-cholinedeficient diet. Laboratory Investigation. J Technical Methods and Pathology. 2010;90:245-256.
20 Heo J. Hwang sil donguibogam. Seoul: Geumjinpublishing. 1993;927.
21 Kim TJ, Resources plants in Korea. Seoul:Seoul National University Publishing Council, 1986;232.
22 Kubo M, Fujita K. A new irisolidone-7-Oglucoside and tectoridin from Pueraria species. Phytochemistry. 1973;12:25-47.   DOI
23 Kubo M, Sasaki M, Namba K, Naruto S, Nishimura H. Isolation of a new isoflavone from chinese Pueraria Flower. Chem Pharm Bull. 1975;23:2449-2451.   DOI
24 Kurihara T, Kikuchi. Studies on the constituents of Flower (1): On the constituents of Flower of Pueraria thunbergiana Benth (2). Isolation of a new isoflavone glycoside. Yakugaku Zasshi. 1975;95: 1283-1285.   DOI
25 Park HJ, Park JH, Moon JO, Lee KT, Jung WT, Oh SR, Lee HK. Isoflavone glycosides from the Flower of Pueraria thunbergiana. Phytochemistry. 1999;51:147-151.   DOI
26 Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in sterptozotocin-induced diabetic rats. J Nature Products. 2003;66:788-792.   DOI
27 Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231.   DOI
28 Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharmacal Res. 2007;30:1309-1317.   DOI
29 Falchuk FR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology. 1980;78:535-541.
30 Bacon BR. Genetic, metabolic, and infiltrative diseases affecting the liver. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill. 2008;1980-1983
31 Yun JW, Cho YK. Clinical impact of non-alcoholic fatty liver disease on other medical diseases. Korean J Intern Med. 2009;76(1):25-29.
32 Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis. 2002;6(2):399-420.   DOI
33 Leevy CM. Fatty liver. A study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine. 1962;41:249-276.   DOI
34 Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12: 1106-1110.   DOI
35 Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand. 1986;220:83-88.
36 Kim MJ, Park CH, Kim DH, Park MH, Park KC, Hyun MK, Lee AK, Moon HR, Chung HY. Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats. Molecules. 2018;23(8). doi: 10.3390/molecules23082057.   DOI